Valuation & Market

With a major strategic pivot complete, Gibraltar Industries' leadership will outline its 2026 playbook to investors at a key 'New Ideas' conference.

TriSalus Life Sciences reports record 53% annual revenue growth, but a closer look reveals a complex financial picture for the oncology innovator.

Koppers Holdings navigates a key leadership change as CFO Jimmi Sue Smith retires. Veteran Bradley Pearce takes the helm as interim financial chief.

Global hygiene firm Essity sees a contentious bondholder lawsuit discontinued with no compensation paid, closing a chapter that tested corporate debt covenants.

A $10 billion fund. Two competing visions. Wingspan Advisors' unique 'Alpha Summit' will decide the future of its ambitious new investment vehicle.

South Korean gim specialist Daingt is leveraging proprietary data and a 20-year legacy to innovate its seaweed, aiming to dominate the booming global market.

Garnering top ESG ratings, multiple Newsweek awards, and its first LEED certification, Park Hotels proves sustainability is a core business strategy.

As Harmony Biosciences presents at JPM, investors will scrutinize its strategy for sustaining growth beyond its star drug and advancing its rare disease pipeline.

The newly formed food tech giant will outline its strategic priorities, with investors closely watching for synergy updates and future growth plans.

A strategic bet on ethnic grocery-anchored retail pays off as Arc Capital Partners exits a revitalized Torrance center in a $108.5 million blockbuster deal.

Built In names its 2026 top workplaces, but as AI reshapes hiring, a critical look reveals what these accolades truly mean for your career.

The digital commerce leader appoints seasoned executives to scale its enterprise playbook and accelerate adoption of AI-driven, composable commerce solutions.

TCS's new Digital Twindex report outlines a future of intelligent, learning vehicles. But the road from hype to reality is paved with challenges.

With surging revenue for its cholesterol drugs and new guideline backing, Esperion outlines its strategy for profitability and pipeline expansion.

The AI defense firm is cleaning its balance sheet by converting debt to stock, a move that strengthens its finances but dilutes existing shareholders.

Lantheus sells its legacy SPECT business to fusion-tech firm SHINE, sharpening its focus on high-growth PET diagnostics and next-gen cancer therapies.

Genelux appoints Dr. Jason Litten as CMO, a strategic move to steer its promising oncolytic virus, Olvi-Vec, through crucial late-stage cancer trials.

With CEO David Endicott set to present at the J.P. Morgan Healthcare Conference, all eyes are on Alcon's strategy for innovation and market growth.

Fitch Ratings awards NETSTREIT a BBB- rating, a milestone affirming its conservative strategy and unlocking new avenues for growth and capital efficiency.

PacBio heads to J.P. Morgan's conference with new tech aimed at making long-read sequencing cheaper. Can it challenge rivals and win over investors?